Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID -- Ignore unavailable to you. Want to Upgrade?

To: Roudy who wrote (1358)	11/20/1997 2:16:00 PM
From: HARRY GIBSON	Read Replies (1) \| Respond to of 1762

I don't know about lurkers. Myself, I waiting for the second shoe of the FDA approval to drop to see if this stock can rock and roll. Judging from the volumn so is everybody else. Just my opinion thank you.

To: Roudy who wrote (1358)	11/21/1997 9:38:00 AM
From: aknahow	Respond to of 1762

IDEC is in favor with both Murphy and McCamant who will both be speakng at the conference you mention. BTW they both also like Xoma which made the IDEC breakthrough possible. If any one here learns amount of royality that will be paid to Xoma please post. I am using 2% in the absences of any better info. Agree that this small participatio does not make Xoma another way to participate in IDECs good fortune but it does validate their capabilitie to some extent.